CausalSentinel

Protein Dossier — MED1 (Methyl-CpG-binding domain protein 4)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Pancreatic cancer 0.176 0.115 0.125 Wald ratio 1 trans NA
Melanoma -0.152 0.184 0.407 Wald ratio 1 trans NA
Intracranial volume -3.37e+03 4.6e+03 0.463 Wald ratio 1 trans NA

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3891_56_1 MBD4 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

36 association rows across 31 traits (32 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Hematological traits (multi-trait analysis) 4e-95 rs145835664 1 GCST90838669 no MR -> candidate analysis
Estimated glomerular filtration rate (creatinine) 4e-48 rs55722796 1 GCST90103634 no MR -> candidate analysis
Circulating EPCAM levels 2e-26 rs4795369 1 GCST90859956 no MR -> candidate analysis
Asthma (childhood onset) 8e-23 rs145835664 1 GCST009841 no MR -> candidate analysis
EPCAM protein levels 4e-22 rs4795369 1 GCST90469126 no MR -> candidate analysis
Neutrophil-to-lymphocyte ratio 5e-20 rs145835664 4 GCST90866310 no MR -> candidate analysis
SLC51B protein levels 2e-19 rs4795369 1 GCST90470664 no MR -> candidate analysis
Blood urea nitrogen (BUN, maximum, inv-norm transformed) 3e-17 rs12943928 1 GCST90479524 no MR -> candidate analysis
Drinks per week 6e-16 rs55722796 1 GCST90243989 no MR -> candidate analysis
White blood cell count 9e-16 rs72825193 1 GCST007070 no MR -> candidate analysis
Asthma 2e-14 rs146644295 1 GCST008916 no MR -> candidate analysis
Creatinine levels 2e-14 rs4795361 2 GCST90827754 no MR -> candidate analysis
…and 19 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 784 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
asthma 0.355 common-variant locus no MR -> candidate analysis
coronary atherosclerosis 0.097 common-variant locus no MR -> candidate analysis
systolic heart failure 0.086 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Methyl-CpG-binding domain protein 4)
gnomAD constraint pLI=1, LOEUF=0.21 — LoF-INTOLERANT
GWAS Catalog 112 unique SNPs / 234 rows
ClinVar 194 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance